Eliza Mari Kwesi-Maliepaard

Eliza Mari Kwesi-Maliepaard

Auto-generated profile, based on publicly available information

Eliza Mari Kwesi-Maliepaard

Division of Gene Regulation, Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2014 in Developmental Biology
Verified
Journal Article
Closed access
MBMonique C.M. Balemans
Monique C.M. Balemans
MAMuhammad Ansar
Muhammad Ansar
AOAstrid R. Oudakker
Astrid R. Oudakker
ACArjan P.M. van Caam
Arjan P.M. van Caam
BBBrenda Bakker
Brenda Bakker
Hans Van BokhovenHans Van Bokhoven
Hans Van Bokhoven

6 August 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
EKEliza Mari Kwesi-Maliepaard
Eliza Mari Kwesi-Maliepaard
MAMuhammad Assad Aslam
Muhammad Assad Aslam
MAMir Farshid Alemdehy
Mir Farshid Alemdehy
TBTeun van Den Brand
Teun van Den Brand
CMChelsea McLean
Chelsea McLean
HJHeinz Jacobs
Heinz Jacobs
Significance: Cytotoxic CD8 + T cells control infectious diseases as well as cancer. Memory T cells are a subset of CD8 + T cells that have previously encountered and rapidly responded to a specific antigen. Here we identified the epigenetic writer DOT1L as a central regulator of T cell physiology. In the absence of DOT1L, which methylates histone H3K79 at active genes, cytotoxic T cells prematurely acquired memory features without having encountered an antigen. However, loss of DOT1L in the T cell lineage led to a compromised immune response. Our findings highlight the importance of epigenetic signals in regulating T cell differentiation. Understanding these epigenetic signals is important for developing strategies to modulate T cell immunity.

7 January 2021 in EMBO Reports
Verified
Journal Article
Open access
PDF file
MAMuhammad Assad Aslam
Muhammad Assad Aslam
MAMir Farshid Alemdehy
Mir Farshid Alemdehy
EKEliza Mari Kwesi-Maliepaard
Eliza Mari Kwesi-Maliepaard
FMFitriari Izzatunnisa Muhaimin
Fitriari Izzatunnisa Muhaimin
MCMarieta Caganova
Marieta Caganova
FLFred van Leeuwen
Fred van Leeuwen
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 October 2017 in Cancer Letters
Verified
Journal Article
Closed access
JPJade Peres
Jade Peres
EKEliza M. Kwesi-Maliepaard
Eliza M. Kwesi-Maliepaard
FRFlorian Rambow
Florian Rambow
LLLionel Larue
Lionel Larue
Sharon PrinceSharon Prince
Sharon Prince

16 August 2021 in Cellular and Molecular Life Sciences
Verified
Journal Article
Open access
PDF file
EKEliza Mari Kwesi-Maliepaard
Eliza Mari Kwesi-Maliepaard
HJHeinz Jacobs
Heinz Jacobs
FLFred van Leeuwen
Fred van Leeuwen
Conventional CD8+ memory T cells develop upon stimulation with foreign antigen and provide increased protection upon re-challenge. Over the past two decades, new subsets of CD8+ T cells have been identified that acquire memory features independently of antigen exposure. These antigen-inexperienced memory T cells (TAIM) are described under several names including innate memory, virtual memory, and memory phenotype. TAIM cells exhibit characteristics of conventional or true memory cells, including antigen-specific responses. In addition, they show responsiveness to innate stimuli and have been suggested to provide additional levels of protection toward infections and cancer. Here, we discuss the current understanding of TAIM cells, focusing on extrinsic and intrinsic molecular conditions that favor their development, their molecular definitions and immunological properties, as well as their transcriptional and epigenetic regulation.

1 December 2019 in Melanoma Research
Verified
Journal Article
Closed access
CSCatarina Salgado
Catarina Salgado
EKEliza Mari Kwesi-Maliepaard
Eliza Mari Kwesi-Maliepaard
AJAart G. Jochemsen
Aart G. Jochemsen
MVMijke Visser
Mijke Visser
MHMark Harland
Mark Harland
NGNelleke Gruis
Nelleke Gruis
A proportion of patients diagnosed with melanoma has a positive family history. Despite increasing knowledge on the genes responsible for familial clustering, the genetic basis in the majority of the families with an inherited predisposition to melanoma remains to be clarified. To identify novel melanoma-susceptibility genes, we applied whole-exome sequencing on DNA from two members of a family with four melanoma cases, not explained by established high penetrance melanoma-susceptibility genes. Whole-exome sequencing identified 10 rare, co-segregating, predicted deleterious missense gene variants. Subsequent co-segregation analysis revealed that only variants in the DOT1L (R409H) and the SLCO4C1 (P597A) genes were present in the other two affected members of this family. DOT1L is a methyltransferase that methylates histone H3 lysine 79 (H3K79). It is involved in maintenance of genomic stability, since mutations in the DOT1L gene have been previously reported to compromise the removal of ultraviolet photoproducts in ultraviolet-irradiated melanocytes, thereby enhancing malignant transformation. We hypothesized that the presence of DOT1L R409H variant might be associated with an increased risk of melanoma, since we found co-segregation of the DOT1L mutation in all four melanoma-affected family members. However, this missense variant did neither lead to detectable loss-of-heterozygosity nor reduction of histone methyltransferase activity in melanoma samples from mutation carriers nor altered ultraviolet-survival of mouse embryonic stem cells containing an engineered homozygous DOT1L R409H mutation. Although functional analysis of this rare co-segregating variant did not reveal compromised histone methyltransferase activity and ultraviolet exposure sensitivity, the role of DOT1L as melanoma susceptibility gene deserves further study.